Then, to evaluate the usefulness of TNRC6B expression as a potential diagnostic biomarker of PCa, we performed a binary logistic regression and ROC curve analysis using the information from 52 tissue samples from TCGA-PRAD. This evidence concerns the gene TNRC6B and prostate adenocarcinoma.